Custom antibody service market

Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Sep 2022
CMI5254
227 Pages
Excel & Pdf
Pharmaceutical

Summary

The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal antibodies are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line.

Global custom antibody service market is estimated to be valued at US$ 444.85 Million in 2022 and expected to reach US$ 930.46 million by 2030, witnessing a CAGR of 9.7 % over the forecast period (2022-2030).

Figure 1. Global Custom Antibody Service Market Share (%), By Region, 2022

Market players are indulged in launching customized services for the development of custom antibodies that are used for research purposes, and this is expected to create lucrative growth opportunities in the custom antibody service market

The increase in organic strategies like new customized service launch is expected to drive the growth the market. For instance, in November 2020, AMSBIO, a leading provider of quality life science research reagents and services, announced the launch of development services for rabbit and mouse recombinant monoclonal antibodies. The DimAb development platform, a technology revolution for monoclonal antibody development, which differs from traditional hybridoma fusion methods, is the foundation for the creation of recombinant monoclonal antibodies. It can extract IgG genes from B cells of animals that have received an immunization. These antibodies aid in the creation and marketability of pharmaceuticals.

Custom Antibody Service Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 444.85 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	9.7%	2030 Value Projection:	US$ 930.46 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Service Type: Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies By Source: Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others) By Application: Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others) By End Users: Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations
Companies covered:	Thermo Fisher Scientific, Inc., Genscript, Abcam plc., Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., BioLegend, Inc., ROCKLAND IMMUNOCHEMICALS, INC., ProMab, Innovagen AB, ProteoGenix, Bio-Techne., Creative Diagnostics., Sino Biological, Inc., RayBiotech Life, Inc., Abbiotec, Inc., ProSci Incorporated, Capralogics, Inc., and Boster Biological Technology
Growth Drivers:	Increasing launch of customized services for the development of custom antibodies
Restraints & Challenges:	Challenges involved in the production of customized antibodies

Figure 2. Global Custom Antibody Service Market Share (%) Analysis, By Product Type, 2022

Advantages of using antibodies for various applications is projected to propel the market growth over the forecast period.

Advantages of antibodies is expected to increase their use for various applications such as research and development, production of therapeutics, etc.

According to the National Center for Biotechnology Information (NCBI): 2020, monoclonal antibodies and polyclonal antibodies are widely used in gold standard techniques such as ELISA, western blotting, flow cytometry, and other affinity based assays or isolation techniques. For ELISA, a monoclonal antibody helps detect a specific antigen of interest. Monoclonal antibodies can also help detect specific cells in flow cytometry. They are also useful for protein purification. Monoclonal antibody can further be used to bind a protein which can then be isolated from its solution.

Global Custom Antibody Service Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Supply chain and manufacturing activities have been disrupted globally, due to lockdowns implemented by governments of countries, restricted movement, and other COVID-19 safety precautions.

Identifying individuals infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a focal point throughout the coronavirus disease (COVID-19) pandemic. This has thus created a public health need for COVID-19 testing that is timely, reliable, and widely available.

Market players and academic or research institutes are engaged in research and development activities for treatment of COVID-19 and due to this there has been increase in custom antibody services for COVID-19. This is expected to positively impact growth of the global custom antibody service market during the COVID-19 pandemic.

Global Custom Antibody Service Market: Restraint

Challenges involved in the production of customized antibodies is the major factor hampering the growth of the custom antibody services market. Some challenges includes:

Low yield: In vitro production cultures often yield less antibody/ml than in vivo ascitic fluid method
Cell death: Maintaining optimal cell growth and viability is essential for high antibody yields and an optimized process
Contamination: In vitro production cultures are subject to risks of contamination associated with long-term cell cultures
Time-consuming: In vitro production cultures often have to be maintained over a long period of time in order to yield desired quantities of antibodies

Table of Content

Table of Contents

*Browse 52 market data tables and 47 figures on "Global Custom Antibody Service Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global custom antibody service market during the forecast period (2022-2030)?

Global custom antibody service Market is estimated to be valued at US$ 444.85 Million in 2022 and expected to exhibit a CAGR of 9.7% between 2022 and 2030.

What are the major factors driving the market growth?

Increasing launch of customized services for the development of custom antibodies is the major driving factor for the market.

Which is the major Product Type segment in the market?

The major type of products in market are monoclonal antibodies.

What are the key factors hampering growth of the market?

Challenges involved in the production of customized antibodies is a major factor restraining factor of the market growth.

Which are the major players operating in the market?

Major players operating in the market include Thermo Fisher Scientific, Inc., Genscript, Abcam plc., Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., BioLegend, Inc., ROCKLAND IMMUNOCHEMICALS, INC., ProMab, Innovagen AB, ProteoGenix, Bio-Techne., Creative Diagnostics., Sino Biological, Inc., RayBiotech Life, Inc., Abbiotec, Inc., ProSci Incorporated, Capralogics, Inc. and Boster Biological Technology.